NXPI vs PCVX · P/E 29, rev $12.27B vs $6.84B cap
NXP Semiconductors NV (NXPI) versus Vaxcyte Inc (PCVX) — a side-by-side from cached financials, not a winner call.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Vaxcyte Inc (PCVX) is a biotechnology company listed on US.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
PCVX does not have a complete income-statement cache yet.
NXPI currently screens at market cap $76.47B and trailing P/E 29.0. PCVX currently screens at market cap $6.84B.
Not investment advice. Open the NXPI and PCVX stock pages for the full models.
Not investment advice.